DCOY earnings: a negative outcome, -9.3%

-9.3%Salarius Pharmaceuticals, Inc. (DCOY) →

On August 10, 2023, Salarius Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -9.3% in the window around the event. It had already run -32.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1093.67

1d before

$991.72

Event day

$932.97

1d after

$1027.29

5d after

Pre-catalyst setup

-32.3%

30-day run-up

7894%

30-day volatility

1.9×

volume spike

DCOY catalyst calendar More earningss Prediction track record Full catalyst calendar